MicroGenDX Revenue and Competitors
Estimated Revenue & Valuation
- MicroGenDX's estimated annual revenue is currently $42.2M per year.
- MicroGenDX's estimated revenue per employee is $297,000
Employee Data
- MicroGenDX has 142 Employees.
- MicroGenDX grew their employee count by -13% last year.
MicroGenDX Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $21.9M | 81 | -15% | N/A | N/A |
#2 | $5.1M | 27 | -23% | N/A | N/A |
#3 | $121.8M | 361 | 5% | N/A | N/A |
#4 | $8.9M | 41 | -7% | N/A | N/A |
#5 | $148.2M | 439 | 5% | N/A | N/A |
#6 | $579.9M | 1534 | 7% | N/A | N/A |
#7 | $6.5M | 30 | -3% | N/A | N/A |
#8 | $13.1M | 54 | 17% | N/A | N/A |
#9 | $44M | 148 | 5% | N/A | N/A |
#10 | $435.8M | 1153 | 17% | N/A | N/A |
What Is MicroGenDX?
Welcome to MicroGen DX!\nMicroGenDX is a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvements Amendments (CLIA) licensed clinical laboratory with more than 12 years of experience in diagnosing molecular-based, laboratory-developed tests. MicroGenDX operates a high-complexity diagnostic laboratory that uses Polymerase Chain Reaction (PCR) \nand Next Generation DNA Sequencing Technology (â??NGS Technologyâ??) â?? rather than the traditional approach of growing cultures â?? to determine the presence of and identify by their genetic markers specific micro-organisms that are the cause of infections.\n\nMicroGenDXâ??s technology and mission are improving and saving the lives of patients with serious and often chronic infections and diseases by using the latest science and the most precise diagnostic tool available to identify the cause of infection so that the most effective medicine can be prescribed to treat that infection. Thousands of patients with chronic and often life-threatening infections have benefited from MicroGenDXâ??s work.
keywords:N/A
N/A
Total Funding
142
Number of Employees
$42.2M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MicroGenDX's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | |
2 | Chief Technology Officer | |
3 | Laboratory Manager | |
4 | National Director, Dental Sales and Oral Systemic Health | |
5 | Technical Supervisor | |
6 | Director Business Development | |
7 | Account Executive | |
8 | Sales Account Executive | |
9 | Email Marketer | |
10 | Sales Professional |
MicroGenDX News
This article was sponsored by MicroGenDX. URINARY TRACT INFECTIONS (UTIs) are a common outpatient infection, especially in women aged over...
... unit is now operational for Gypsum, Eagle, Edwards, and El Jebel through a partnership with Roaring Fork Neurology and MicroGenDx.
Other Companies in Orlando
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23.4M | 142 | N/A | N/A |
#2 | N/A | 142 | 89% | N/A |
#3 | $39.1M | 142 | -1% | N/A |
#4 | $45.3M | 142 | -15% | N/A |
#5 | $32.8M | 142 | 0% | N/A |